Komori
General Meetings of Shareholders4875MediciNova,Inc.Pharmaceuticals

Notice of Convocation of the 2026 Annual General Meeting

The annual meeting of stockholders will be held on 23 June 2026 to submit to stockholders proposals regarding the election of 2 directors, the appointment of an independent registered public accounting firm, an amendment to the certificate of incorporation to increase the number of authorized shares of common stock, approval to adjourn the meeting, and other matters.

Worth reading
67In focus
Scored from 3 of 4 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
147000000
Shares (authorized common stock: from 100,000,000 shares to 247,000,000 shares)
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (2026 Annual Meeting)
2026
Jun 23
Date and time(Tuesday), 1:00 p.m. Pacific Daylight Time28 days from this disclosure to the meeting
Matters for resolution5 items
  1. 1 Election of Class I directors, Nagao Hideki (長尾秀樹) and Nicole Lumeron

  2. 2 Approval of the appointment of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending 31 December 2026

  3. 3 Approval of an amendment to the amended and restated certificate of incorporation to increase the number of authorized shares of common stock from 100,000,000 shares to 247,000,000 shares

  4. 4 Approval to adjourn this annual meeting of stockholders to a later date to permit further solicitation of proxies and voting

  5. 5 Consideration of other matters properly brought before this annual meeting of stockholders

Shareholder Proposal

None (at present, there are no proposals other than those described above to be voted on at this annual meeting of stockholders)

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee2 candidates, of whom the number who are new nominees and outside directors is Not disclosed
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (2026 Annual Meeting)
Date and time23 June 2026 (Tuesday), 1:00 p.m. Pacific Daylight Time
Matters for resolution1 Election of Class I directors, Nagao Hideki (長尾秀樹) and Nicole Lumeron, 2 Approval of the appointment of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending 31 December 2026, 3 Approval of an amendment to the amended and restated certificate of incorporation to increase the number of authorized shares of common stock from 100,000,000 shares to 247,000,000 shares, 4 Approval to adjourn this annual meeting of stockholders to a later date to permit further solicitation of proxies and voting, 5 Consideration of other matters properly brought before this annual meeting of stockholders
Shareholder ProposalNone (at present, there are no proposals other than those described above to be voted on at this annual meeting of stockholders)
Director nominee2 candidates, of whom the number who are new nominees and outside directors is Not disclosed
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The specific reason for the increase in the number of authorized shares of common stock is not stated in the portion of the materials provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 2026 Annual General Meeting | MediciNova,Inc. (4875) timely disclosure | Komori